Follow the 스피어 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 스피어 has published 70 insider filings. Market capitalisation: €1,297.7bn. The latest transaction was filed on 11 May 2026 (Sale). Among the most active insiders: 한종현. All data is accessible without an account.
70
Insider Decl.
0
Thresholds
·
24 ops.
Buy Volume
€639,870
12 ops.
Sell Volume
33Σ signal
Buys ·€639,870 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,177 of 26,212 companies
41.7
score / 100
Value
32
Quality
52
FCF yld-1.4%
Earn yld0.0%
EV/EBITDA·
ROE55%
Gross mgn18%
Net mgn0.2%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.